Effect of aspirin in pregnant women is dependent on increase in bleeding time
Article Abstract:
Pregnant women at risk of preeclampsia should be given enough aspirin to significantly increase their bleeding time. Preeclampsia is a complication of pregnancy characterized by hypertension and abnormal blood clotting. Consequently, pregnant women at risk for preeclampsia are often given aspirin, which inhibits blood clotting. Researchers analyzed aspirin use by 187 pregnant women at risk of preeclampsia. The treatment was most successful when begun early in pregnancy. Also, a dose that led to an increase in bleeding time equal to or greater than two minutes was most successful.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
Prevention of preeclampsia: a big disappointment
Article Abstract:
Researchers have had little success in identifying drugs or substances which might prevent preeclampsia in pregnancy. Preeclampsia is a complex disorder characterized by high blood pressure and excessive secretion of protein in the urine, and a major cause of illness and death in pregnant women and their fetuses. Aspirin, calcium, magnesium, zinc, fish oil, and antihypertensive drugs have proven of little or no benefit in preventing the condition.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Preeclampsia prevention: lessons from the low-dose aspirin therapy trials
Article Abstract:
More research is needed to identify pregnant women who will benefit from taking aspirin to prevent pre-eclampsia. Pre-eclampsia is a serious complication of pregnancy. Nineteen clinical trials have shown that some women benefit from taking aspirin, but others do not.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Levels of maternal serum alpha-fetoprotein (AFP) in pregnant women and subsequent breast cancer risk. Beyond the twinning effect: invited commentary on "Levels of maternal serum alpha-fetoprotein (AFP) in pregnant women and subsequent breast cancer risk." (response to article in this issue, p. 719)
- Abstracts: Vasoactive intestinal polypeptide loses its ability to increase vaginal blood flow after menopause. Risk factors among young women with endometrial cancer: a Danish case-control study
- Abstracts: Diet and vitamin D status among pregnant Pakistani women in Oslo. Adipose tissue fatty acids and risk of myocardial infarction - a case-control study
- Abstracts: Know how: Treatment for childhood eczema. Keeping up appearances. Using emollients
- Abstracts: Several Classes of New Drugs Emerging for Parkinson Disease. Dopamine Agonists in Early Therapy for Parkinson Disease: Promise and Problems